- Home
- CDIO vs WNW Comparison
CDIO vs WNW Comparison
Compare CDIO & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDIO | WNW |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | China |
| Employees | 17 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 4.3M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CDIO | WNW |
|---|---|---|
| Price | $1.84 | $3.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.4K | ★ 183.2K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $171,906.75 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.97 | $0.05 |
| 52 Week High | $7.91 | $13.52 |
Technical Indicators
Market Signals| Indicator | CDIO | WNW |
|---|---|---|
| Relative Strength Index (RSI) | 38.66 | 50.54 |
| Support Level | $1.68 | $2.95 |
| Resistance Level | $2.16 | $4.36 |
| Average True Range (ATR) | 0.17 | 0.35 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 0.00 | 37.62 |
Price Performance
Historical ComparisonAbout CDIO Cardio Diagnostics Holdings Inc.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.